Ventilator-based Inspiratory Muscle Training for Patients With Respiratory Failure
1 other identifier
interventional
60
1 country
1
Brief Summary
This study will be conducted to compare the effectiveness of progressive inspiratory flow trigger sensitivity rising versus stepwise pressure support reduction as ventilator-based inspiratory muscle training methods on weaning and extubation success in mechanically ventilated patients with respiratory failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
January 20, 2026
January 1, 2026
11 months
December 1, 2025
January 17, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Spontaneous breathing trial (SBT)
documenting the frequency (total number) of spontaneous breathing trials for each patient until successful extubation
From initiation of the first SBT until successful extubation, up to 48 hours
Burn's Wean Assessment Score
Calculate the percentage of the total score to indicate the extent of improvement and the probable readiness for weaning (in %). The 26-item checklist assigns 1 point for "yes" responses, with a total score up to 26. Scores below 17 (65%) suggest insufficient readiness for weaning, while scores ≥ 17 indicate probable readiness for weaning.
baseline (Day 1, prior to intervention) and immediately before initiation of successful SBT
Duration of MV
defined as the time from study randomization to successful unassisted breathing (in days)
from randomization to successful unassisted breathing, up to 48 hours
weaning success rate
absence of ventilatory support 48 hours after discontinuation of MV. Inability to tolerate or pass SBT or to be liberated from invasive ventilatory support indicates weaning failure (in %).
Within 48 hours following extubation
Extubation success rate
defined as the proportion of subjects who did not die and were not re-intubated 48-72 hours after the scheduled extubation. The inability to sustain spontaneous breathing after removal of the endotracheal tube, requiring either reintubation or the use of NIV within this specified period, indicates extubation failure (in %).
Within 72 hours following extubation
Secondary Outcomes (8)
Blood Gas analysis
baseline (Day 1, prior to intervention) and within 48 hours after liberation from mechanical ventilation
Negative Inspiratory Force
Baseline (Day 1, prior to intervention) and immediately following completion of successful SBT
Respiratory Rate
Baseline (Day 1, prior to intervention) and immediately following completion of successful SBT
Minute Ventilation
Baseline (Day 1, prior to intervention) and immediately following completion of successful SBT
Static Lung-Thorax Compliance
Baseline (Day 1, prior to intervention) and immediately following completion of successful SBT
- +3 more secondary outcomes
Study Arms (3)
Conventional Chest Physiotherapy
PLACEBO COMPARATORtwenty mechanically ventilated patients with acute respiratory failure, who will receive the routine plan of weaning and conventional chest physiotherapy from MV twice a day with a 4-6 hour gap between for 4-5 days a week till extubation.
Trigger Sensitivity IMT
EXPERIMENTALtwenty mechanically ventilated patients with acute respiratory failure, who will receive inspiratory muscle training by gradual inspiratory flow trigger sensitivity optimization in addition to the routine plan of weaning and conventional chest physiotherapy from MV, twice a day with a 4-6 hour gap between, for 4-5 days a week till extubation.
Stepwise Pressure Support Reduction IMT
EXPERIMENTALtwenty mechanically ventilated patients with acute respiratory failure, who will receive inspiratory muscle training via stepwise pressure support reduction in addition to the routine plan of weaning and conventional chest physiotherapy from MV, twice a day with a 4-6 hour gap between, for 4-5 days a week till extubation.
Interventions
adjust the parameters of the mode of training on mechanical ventilation according the group of patients
Chest Physiotherapy including: ▪ Postural Drainage ▪ Manual techniques for airway clearance (percussion, vibration, shaking) Adding to range of passive to active movements of the limbs
Eligibility Criteria
You may qualify if:
- Acute respiratory failure patients in the ICU are receiving MV for 48 h or more in a controlled mode.
- Their ages will range from 40 to 55 years old, and both sexes will be included.
- Conscious and oriented patients with a Glasgow coma score ≥13 (≥9T).
- Alertness score with a Richmond Agitation-Sedation Scale (RASS) will be from 0 to -1.
- All patients in this study must be hemodynamically and medically stable.
- Patients must be able to trigger spontaneous breaths on the ventilator but couldn't generate maximum inspiratory pressure more than -15 mbar.
You may not qualify if:
- Persistent hemodynamic instability as life-threatening conditions or comorbidities interfere with and compromise weaning, like cardiac arrhythmia, pericardial effusion, congestive heart failure, or acute coronary syndrome.
- Severe breathlessness when spontaneously breathing.
- Any progressive neuromuscular disease, such as myopathy or neuropathy, that would interfere with responding to inspiratory muscle training due to inadequate training performance of the inspiratory muscle.
- Spinal cord injury.
- Skeletal pathology (scoliosis, flail chest, spinal instrumentation) that would seriously impair the movement of the chest wall and ribs.
- Patients in a coma or under heavy sedation (RASS ≤ -2) and with respiratory muscle paralysis.
- High peak airway pressure (barotrauma), high PEEP \>10, or active pneumothorax.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
kasr Al Ainy Hospital
Cairo, Giza Governorate, 11956, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mahmoud E Ragab, M.Sc.
Kasr Al Ainy hospital, Cairo University
- STUDY CHAIR
Nesreen G' EL-NAHAS, PhD
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- only the investigator knows the applied training method, once randomization is happened and the patient enrolled in his specific group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer Dr.
Study Record Dates
First Submitted
December 1, 2025
First Posted
January 20, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
data is available with the corresponding author on reasonable request